Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 180,654	$ 145,924
Marketable investments	41,949	171,390
Accounts receivable, net of allowance for credit losses of $5,011 and $2,497, respectively	53,079	45,562
Inventories, net	68,668	63,628
Other current assets and prepaid expenses	24,900	24,036
Restricted cash	700	700
Total current assets	369,950	451,240
Property and equipment, net	65,511	40,368
Deferred tax assets	547	590
Goodwill	1,339	1,339
Operating lease right-of-use assets	11,370	12,831
Other long-term assets	15,113	14,620
Total assets	463,830	520,988
Current liabilities:
Accounts payable	34,240	33,736
Accrued liabilities	53,764	57,452
Operating lease liabilities	2,602	2,810
Deferred revenue	12,457	11,841
Total current liabilities	103,063	105,839
Deferred revenue, net of current portion	1,690	1,657
Operating lease liabilities, net of current portion	10,069	11,352
Convertible notes, net of unamortized debt issuance costs of $11,557 and $12,666, respectively	417,568	416,459
Other long-term liabilities	575	862
Total liabilities	532,965	536,169
Commitments and Contingencies (Note 13)
Stockholders’ deficit:
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 19,901,600 and 19,668,603 shares at June 30, 2023 and December 31, 2022, respectively	20	20
Additional paid-in capital	128,014	125,406
Accumulated other comprehensive income (loss)	4	(94)
Accumulated deficit	(197,173)	(140,513)
Total stockholders’ deficit	(69,135)	(15,181)
Total liabilities and stockholders’ deficit	$ 463,830	$ 520,988